Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center

Abstract Objective: To evaluate the accuracy of magnetic resonance imaging (MRI) of the breasts in the identification of a pathological complete response in patients with breast cancer undergoing neoadjuvant chemotherapy (NAC). Materials and Methods: This was a single-center, retrospective, observational study designed to validate a diagnostic test. The following variables were evaluated: age; results of the histological and immunohistochemical analysis of the biopsy; post-NAC MRI findings; and results of the histological analysis of the surgical specimen, using the residual cancer burden index. The radiological response, as assessed by MRI, was compared with the pathological response, as assessed by histological analysis of the surgical specimen (the gold standard method). Results: We evaluated 310 tumors in 308 patients. The mean age of the patients was 47 years (range, 27-85 years). For identifying a pathological complete response, breast MRI had an overall accuracy of 79%, with a sensitivity of 75%, specificity of 83%, positive predictive value of 75%, and negative predictive value of 83%. When that accuracy was stratified by molecular subtype, it was best for the HER2 subtype, with a sensitivity and specificity of 82% and 89%, respectively, followed by the triple-negative subtype, with a sensitivity and specificity of 78% and 83%, respectively. Conclusion: Breast MRI showed good accuracy in the prediction of a pathological complete response after NAC. The sensitivity and positive predictive value were highest for the HER2 and triple-negative subtypes.

Saved in:
Bibliographic Details
Main Authors: Negrão,Erika Marina Solla, Bitencourt,Almir Galvão Vieira, Souza,Juliana Alves de, Marques,Elvira Ferreira
Format: Digital revista
Language:English
Published: Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842019000500299
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-39842019000500299
record_format ojs
spelling oai:scielo:S0100-398420190005002992019-10-21Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer centerNegrão,Erika Marina SollaBitencourt,Almir Galvão VieiraSouza,Juliana Alves deMarques,Elvira Ferreira Breast neoplasms Drug therapy, combination Magnetic resonance imaging Triple negative breast neoplasms Receptor, ErbB-2 Abstract Objective: To evaluate the accuracy of magnetic resonance imaging (MRI) of the breasts in the identification of a pathological complete response in patients with breast cancer undergoing neoadjuvant chemotherapy (NAC). Materials and Methods: This was a single-center, retrospective, observational study designed to validate a diagnostic test. The following variables were evaluated: age; results of the histological and immunohistochemical analysis of the biopsy; post-NAC MRI findings; and results of the histological analysis of the surgical specimen, using the residual cancer burden index. The radiological response, as assessed by MRI, was compared with the pathological response, as assessed by histological analysis of the surgical specimen (the gold standard method). Results: We evaluated 310 tumors in 308 patients. The mean age of the patients was 47 years (range, 27-85 years). For identifying a pathological complete response, breast MRI had an overall accuracy of 79%, with a sensitivity of 75%, specificity of 83%, positive predictive value of 75%, and negative predictive value of 83%. When that accuracy was stratified by molecular subtype, it was best for the HER2 subtype, with a sensitivity and specificity of 82% and 89%, respectively, followed by the triple-negative subtype, with a sensitivity and specificity of 78% and 83%, respectively. Conclusion: Breast MRI showed good accuracy in the prediction of a pathological complete response after NAC. The sensitivity and positive predictive value were highest for the HER2 and triple-negative subtypes.info:eu-repo/semantics/openAccessPublicação do Colégio Brasileiro de Radiologia e Diagnóstico por ImagemRadiologia Brasileira v.52 n.5 20192019-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842019000500299en10.1590/0100-3984.2018.0149
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Negrão,Erika Marina Solla
Bitencourt,Almir Galvão Vieira
Souza,Juliana Alves de
Marques,Elvira Ferreira
spellingShingle Negrão,Erika Marina Solla
Bitencourt,Almir Galvão Vieira
Souza,Juliana Alves de
Marques,Elvira Ferreira
Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
author_facet Negrão,Erika Marina Solla
Bitencourt,Almir Galvão Vieira
Souza,Juliana Alves de
Marques,Elvira Ferreira
author_sort Negrão,Erika Marina Solla
title Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
title_short Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
title_full Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
title_fullStr Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
title_full_unstemmed Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
title_sort accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
description Abstract Objective: To evaluate the accuracy of magnetic resonance imaging (MRI) of the breasts in the identification of a pathological complete response in patients with breast cancer undergoing neoadjuvant chemotherapy (NAC). Materials and Methods: This was a single-center, retrospective, observational study designed to validate a diagnostic test. The following variables were evaluated: age; results of the histological and immunohistochemical analysis of the biopsy; post-NAC MRI findings; and results of the histological analysis of the surgical specimen, using the residual cancer burden index. The radiological response, as assessed by MRI, was compared with the pathological response, as assessed by histological analysis of the surgical specimen (the gold standard method). Results: We evaluated 310 tumors in 308 patients. The mean age of the patients was 47 years (range, 27-85 years). For identifying a pathological complete response, breast MRI had an overall accuracy of 79%, with a sensitivity of 75%, specificity of 83%, positive predictive value of 75%, and negative predictive value of 83%. When that accuracy was stratified by molecular subtype, it was best for the HER2 subtype, with a sensitivity and specificity of 82% and 89%, respectively, followed by the triple-negative subtype, with a sensitivity and specificity of 78% and 83%, respectively. Conclusion: Breast MRI showed good accuracy in the prediction of a pathological complete response after NAC. The sensitivity and positive predictive value were highest for the HER2 and triple-negative subtypes.
publisher Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842019000500299
work_keys_str_mv AT negraoerikamarinasolla accuracyofbreastmagneticresonanceimaginginevaluatingtheresponsetoneoadjuvantchemotherapyastudyof310casesatacancercenter
AT bitencourtalmirgalvaovieira accuracyofbreastmagneticresonanceimaginginevaluatingtheresponsetoneoadjuvantchemotherapyastudyof310casesatacancercenter
AT souzajulianaalvesde accuracyofbreastmagneticresonanceimaginginevaluatingtheresponsetoneoadjuvantchemotherapyastudyof310casesatacancercenter
AT marqueselviraferreira accuracyofbreastmagneticresonanceimaginginevaluatingtheresponsetoneoadjuvantchemotherapyastudyof310casesatacancercenter
_version_ 1756386917332549633